Status:

UNKNOWN

THE LASER-AMI STUDY - Excimer Laser Versus Manual Thrombus Aspiration in Acute Myocardial Infarction

Lead Sponsor:

Catholic University of the Sacred Heart

Conditions:

Myocardial Infarction

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

The occurrence of no-reflow phenomenon after recanalization of the infarct related artery in acute myocardial infarction is described in up to 40% of cases. This event is associated with a worse progn...

Detailed Description

Acute myocardial infarction (AMI) is the leading cause of death in developed countries. In patients with AMI, prompt reopening of an occluded coronary artery is the main goal of reperfusion therapies ...

Eligibility Criteria

Inclusion

  • Onset of symptoms of MI less than 12 hours prior to enrolment;
  • ST-segment elevation of at least 2 mm in two or more contiguous leads;
  • Vessel and lesion amenable to both coronary laser and manual trhombus aspiration (lack of marked vessel/lesion tortuosity or calcification; reference vessel diameter \>2.5 mm in diameter);
  • Written informed consent.

Exclusion

  • Rescue angioplasty after failed thrombolysis;
  • Stent thrombosis;
  • Culprit lesion located in a bypass graft or in the left main trunk;
  • Cardiogenic shock;
  • Young age (\< 18 years);
  • Severe renal failure (creatinine clearance ≤30 ml/min);
  • Concomitant disease resulting in a life expectancy of less than 6 months;
  • Pregnancy;
  • Contraindications to contrast agents not manageable medically, or to study medications, including aspirin, clopidogrel, ticlopidine and heparin;
  • Left bundle branch block, paced rhythm, frequent ventricular ectopy, pre-excitation or other ECG abnormalities interfering with the analysis of ST-segment resolution;
  • Markedly depressed LV function (LVEF \<30%); Culprit lesion cannot be identified;
  • Severe left main or triple vessel disease requiring CABG during the index hospitalization;
  • Patients already involved in other ongoing trials;
  • Patients unable or unwilling to give their informed consent.

Key Trial Info

Start Date :

April 1 2014

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

Estimated Enrollment :

194 Patients enrolled

Trial Details

Trial ID

NCT01826006

Start Date

April 1 2014

Last Update

November 13 2014

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Dipartimento Medicina Cardiovascolare

Rome, Italy, 00168